AI brief of an SEC Form 8-K · Trupanion (TRUP)

Trupanion appoints Bradley Powell, former Expeditors CFO, to its board of directors

Neutral Impact 2 of 5 leadership Written later

Trupanion's board appointed Bradley S. Powell as a director on October 29, 2025. Powell previously served as CFO of Expeditors International of Washington from October 2008 to September 2025, and the company describes him as bringing accounting and financial expertise to the board. The filing says he is an independent director and will serve until the 2026 annual meeting of stockholders.

Key points

  • Appointed to the board on October 29, 2025; term expires at the 2026 annual meeting of stockholders
  • Served as CFO of Expeditors International of Washington from October 2008 to September 2025
  • Previously CFO of Eden Bioscience Corporation from July 1998 to September 2008
  • Filing states he is an independent director under Nasdaq rules and will join the non-employee director compensation program

The filing

CompanyTrupanion (TRUP)
Form8-K, current report
Filed with the SECOct 30, 2025, 4:15 PM ET
Accession number0001371285-25-000238

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.